Human papillomavirus vaccination coverage among adolescents, 2007–2013, and postlicensure vaccine safety monitoring, 2006–2014 — United States

Morbidity and Mortality Weekly Report

Volumn , Issue 29, 2014, Pages 620-624

  Stokley, Shannon ^a   Jeyarajah, Jenny ^a   Yankey, David ^a   Cano, Maria ^b   Gee, Julianne ^b   Roark, Jill ^a   Robinette Curtis, C ^a   Markowitz, Lauri ^c  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ARTICLE; FEMALE; HUMAN; IMMUNIZATION; MALE; PAPILLOMAVIRUS INFECTION; POSTMARKETING SURVEILLANCE; SAFETY; UNITED STATES; UTILIZATION REVIEW; VACCINATION;

ADOLESCENT; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; MALE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PRODUCT SURVEILLANCE, POSTMARKETING; SAFETY; UNITED STATES; VACCINATION;

EID: 84904581436     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. CDC. Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2007;56(No. RR-2k).
2. CDC. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR 2010;59:626-629.
3. CDC. Recommendations on the use of quadrivalent human papillomavirus vaccine in males—Advisory Committee on Immunization Practices (ACIP), 2011. MMWR 2011;60:1705-1708.
4. CDC. General recommendations on immunization: Recommendations of the Advisory Committee on Immunization Practices. MMWR 2011;60(No. RR-2).
5. CDC, National Opinion Research Center at the University of Chicago. National Immunization Survey-Teen: A user’s guide for the 2012 publicuse data file. Chicago, IL: National Opinion Research Center; 2014. Available at http://ftp.cdc.gov/pub/health_statistics/nchs/dataset_documentation/nis/nisteenpuf12_dug.pdf.
6. CDC. Human papillomavirus vaccination coverage among adolescent girls, 2007–2012, and postlicensure vaccine safety monitoring, 2006– 2013—United States. MMWR 2013;62:591-595.
7. Slade BA, Leidel L, Vellozzi C, et al. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA 2009;302:750-757.
8. CDC. National and state vaccination coverage among adolescents aged 13–17 years—United States, 2012. MMWR 2013;62:685-693.
9. Elam-Evans LD, Yankey D, Jeyarajah J, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2013. MMWR 2014;63:625-633.